159 related articles for article (PubMed ID: 25358582)
1. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
[No Abstract] [Full Text] [Related]
2. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment.
Wong JY; Kuzel P; Mullen J; Lien D; Mahmood M; Conrad C; Fiorillo L
Pediatr Transplant; 2014 Sep; 18(6):E200-7. PubMed ID: 25039541
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
[TBL] [Abstract][Full Text] [Related]
4. Treatment of aspergillus-related ulcerative tracheobronchitis in lung transplant recipients.
Birsan T; Taghavi S; Klepetko W
J Heart Lung Transplant; 1998 Apr; 17(4):437-8. PubMed ID: 9588590
[No Abstract] [Full Text] [Related]
5. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.
Kolaitis NA; Duffy E; Zhang A; Lo M; Barba DT; Chen M; Soriano T; Hu J; Nabili V; Saggar R; Sayah DM; DerHovanessian A; Shino MY; Lynch JP; Kubak BM; Ardehali A; Ross DJ; Belperio JA; Elashoff D; Saggar R; Weigt SS
Transpl Int; 2017 Jan; 30(1):41-48. PubMed ID: 27678492
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.
Williams K; Mansh M; Chin-Hong P; Singer J; Arron ST
Clin Infect Dis; 2014 Apr; 58(7):997-1002. PubMed ID: 24363331
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.
Tang H; Shi W; Song Y; Han J
J Am Acad Dermatol; 2019 Feb; 80(2):500-507.e10. PubMed ID: 30130598
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP2C19 *17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma.
Williams K; Arron ST
JAMA Dermatol; 2016 Jun; 152(6):719-20. PubMed ID: 26982740
[No Abstract] [Full Text] [Related]
10. Squamous cell carcinoma in an immunosuppressed patient on voriconazole.
Carrascosa R; Solano-López GE; Vargas E; Fraga J
Actas Dermosifiliogr; 2014 May; 105(4):424-6. PubMed ID: 24007811
[No Abstract] [Full Text] [Related]
11. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
[TBL] [Abstract][Full Text] [Related]
12. Pigmented squamous cell carcinoma in an adolescent following long-term treatment with voriconazole.
Verdú-Amorós J; Wilbrand JF; Mayser P; Gattenloehner S; Woessmann W
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27696679
[No Abstract] [Full Text] [Related]
13. Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Younus M; Mo J; Yan J; Ussetti P; Chin-Hong PV; Solé A; Holmes-Liew CL; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Aram J; Singer LG; Husain S
Am J Transplant; 2018 Jan; 18(1):113-124. PubMed ID: 28898527
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole-induced multiple squamous cell carcinomas in a patient with chronic lymphocytic leukemia.
Patel VA; Parikh SA; Nayyar PM; Ratner D
Dermatol Surg; 2015 Jun; 41(6):747-9. PubMed ID: 25984902
[No Abstract] [Full Text] [Related]
15. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
[TBL] [Abstract][Full Text] [Related]
16. Case of ultraviolet B-mediated photosensitivity during the administration of voriconazole.
Mizuno S; Itoh M; Matsuo H; Kikuchi S; Asahina A
J Dermatol; 2019 Sep; 46(9):e327-e328. PubMed ID: 31021004
[No Abstract] [Full Text] [Related]
17. A Case Report of Mass-Forming Aspergillus Tracheobronchitis Successfully Treated with Voriconazole.
Kim DS; Jeong JS; Kim SR; Jin GY; Chung MJ; Lee YC
Medicine (Baltimore); 2015 Aug; 94(34):e1434. PubMed ID: 26313799
[TBL] [Abstract][Full Text] [Related]
18. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Vanacker A; Fabré G; Van Dorpe J; Peetermans WE; Maes B
Am J Transplant; 2008 Apr; 8(4):877-80. PubMed ID: 18261173
[TBL] [Abstract][Full Text] [Related]
19. Fulminant Tracheobronchial Aspergillosis in an Apparently Healthy Adult.
Moribuchi H; Sato R; Matsushima S; Tominaga M; Sasaki J; Nakamura M; Sakazaki Y; Nishiyama M; Hoshino T; Kawayama T
Intern Med; 2020; 59(10):1295-1298. PubMed ID: 32418954
[TBL] [Abstract][Full Text] [Related]
20. [Aspergillus tracheobronchitis in a lung transplant recipient].
García-Gallo CL; García-Fadul C; Laporta-Hernández R; Ussetti-Gil P
Rev Iberoam Micol; 2011; 28(3):129-33. PubMed ID: 21700233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
